Buøen Elisabet Solheim, Lekhal Ratib, Lydersen Stian, Berg-Nielsen Turid Suzanne, Drugli May Britt
Regional Centre for Child and Adolescent Mental Health, Eastern and Southern Norway, Oslo, Norway.
Department of Communication and Culture, Norwegian Business School, Oslo, Norway.
Front Psychol. 2021 Nov 18;12:778777. doi: 10.3389/fpsyg.2021.778777. eCollection 2021.
The effectiveness of the Thrive by Three intervention, a 10-month, multicomponent, in-service professional development model to promote the quality of caregiver-toddler interactions (i.e., process quality), was tested utilizing a clustered randomized controlled design. Eighty childcare centers with 187 toddler classrooms in Norway were randomly assigned to either the Thrive by Three intervention group (=87) or a usual-activity wait list control group (=100). Interactional quality was assessed with the Toddler version of the Classroom Assessment Scoring System (CLASS-Toddler) at three timepoints: pre-, mid-, and post-intervention. There were significant group differences in change in quality during the intervention period in both CLASS domains, Emotional and Behavioral Support (EBS), and Engaged Support for Learning (ESL), with greater overall differences in the ESL domain. Quality increased in the intervention groups, but quality decreased in the control group from baseline to post-intervention. There were significant group differences in quality at baseline. The Thrive by Three intervention had a positive effect on teacher-toddler interactions in both the EBS and ESL domains. Results need to be replicated preferably in more diverse samples. ClinicalTrials.gov #NCT03879733.
“三岁茁壮成长”干预措施是一种为期10个月的多成分在职专业发展模式,旨在提高照顾者与幼儿互动的质量(即过程质量)。本研究采用整群随机对照设计对该干预措施的有效性进行了测试。挪威的80所儿童保育中心的187间幼儿教室被随机分为“三岁茁壮成长”干预组(=87)或常规活动等待名单对照组(=100)。在干预前、干预中期和干预后三个时间点,使用《课堂评估评分系统幼儿版》(CLASS-Toddler)对互动质量进行评估。在干预期间,两个CLASS领域,即情感和行为支持(EBS)以及参与式学习支持(ESL)的质量变化存在显著的组间差异,ESL领域的总体差异更大。从基线到干预后,干预组的质量有所提高,而对照组的质量则有所下降。基线时两组在质量上存在显著差异。“三岁茁壮成长”干预措施对教师与幼儿在EBS和ESL领域的互动产生了积极影响。研究结果最好在更多样化的样本中进行重复验证。ClinicalTrials.gov #NCT03879733